Telos Capital Management Inc. Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Telos Capital Management Inc. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 25,865 shares of the exchange traded fund’s stock after selling 535 shares during the quarter. Telos Capital Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,309,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Verity Asset Management Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 7.9% during the third quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock worth $1,258,000 after buying an additional 1,266 shares during the period. Prime Capital Investment Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 52.6% during the fourth quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock worth $577,000 after buying an additional 2,228 shares during the period. United Capital Management of KS Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 1.8% during the fourth quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock worth $9,290,000 after buying an additional 1,831 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $10,587,000. Finally, Albion Financial Group UT acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $69,000.

SPDR S&P Biotech ETF Trading Down 0.4 %

Shares of XBI traded down $0.36 during mid-day trading on Wednesday, hitting $85.25. 8,471,241 shares of the company’s stock were exchanged, compared to its average volume of 11,670,182. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market capitalization of $6.62 billion, a P/E ratio of 11.47 and a beta of 1.08. The business’s 50 day moving average is $93.86 and its two-hundred day moving average is $84.12.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.